Skip to main content

Rehabilitation

0
Pipeline Programs
3
Companies
10
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

ETS
ETSMO - Rolla
6 programs
Control groupN/A1 trial
Multimedial RehabilitationN/A1 trial
Participiants at high risk of malnutrition who received standard nutritional careN/A1 trial
Pulmonary rehabilitationN/A1 trial
QoL and the Emotional-affective Sphere in Rehabilitation Setting During COVID-19 QuarantineN/A1 trial
+1 more programs
Active Trials
NCT04186910Unknown20Est. Sep 2020
NCT03025126Completed100Est. Dec 2017
NCT07183098Completed193Est. Dec 2022
+4 more trials
Verona Pharma
Verona PharmaUK - London
2 programs
Cognitive rehabilitation: CG groupN/A1 trial
TelerehabilitationN/A1 trial
Active Trials
NCT06820125Recruiting48Est. Jul 2026
NCT06795672Terminated23Est. Mar 2024
ICU Medical
ICU MedicalCA - San Clemente
1 program
exercisesN/A1 trial
Active Trials
NCT05808361Completed180Est. Jun 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Verona PharmaCognitive rehabilitation: CG group
ETSPulmonary rehabilitation
Verona PharmaTelerehabilitation
ETSQoL and the Emotional-affective Sphere in Rehabilitation Setting During COVID-19 Quarantine
ICU Medicalexercises
ETSControl group
ETSParticipiants at high risk of malnutrition who received standard nutritional care
ETSTreadmill
ETSMultimedial Rehabilitation
ETSTreadmill

Clinical Trials (10)

Total enrollment: 995 patients across 10 trials

NCT06820125Verona PharmaCognitive rehabilitation: CG group

Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation

Start: Jul 2023Est. completion: Jul 202648 patients
N/ARecruiting
NCT06453421ETSPulmonary rehabilitation

Pulmonary Rehabilitation in the Chronically Critically Ill Patient

Start: Feb 2023Est. completion: Aug 2029220 patients
N/ARecruiting
NCT06795672Verona PharmaTelerehabilitation

Tele-rehabilitation for Cognitive Disorders

Start: Mar 2022Est. completion: Mar 202423 patients
N/ATerminated
NCT04408196ETSQoL and the Emotional-affective Sphere in Rehabilitation Setting During COVID-19 Quarantine

QoL and the Emotional-affective Sphere in Rehabilitation Setting During COVID-19 Quarantine

Start: May 2020Est. completion: Feb 2021121 patients
N/ACompleted

Rehabilitation Treatment of Patients With COVID-19

Start: Apr 2020Est. completion: Jun 2021180 patients
N/ACompleted
NCT04186910ETSControl group

In Clinic Physical Activity in Persons With Multiple Sclerosis

Start: Jul 2019Est. completion: Sep 202020 patients
N/AUnknown
NCT07183098ETSParticipiants at high risk of malnutrition who received standard nutritional care

Prevalence and Clinical-Economic Aspects of Malnutrition in Rehabilitation

Start: Apr 2018Est. completion: Dec 2022193 patients
N/ACompleted

Improving Dynamic Balance and Gait Adaptability Using Treadmill Training

Start: Jul 2017Est. completion: Apr 201948 patients
N/AUnknown
NCT03025126ETSMultimedial Rehabilitation

Human Empowerment Aging and Disability (HEAD): New Technologies for Neurorehabilitation

Start: Mar 2016Est. completion: Dec 2017100 patients
N/ACompleted

Intensive Multimodal Training for Persons With MS

Start: Jan 201342 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 995 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.